Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Vanda Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get VNDA alerts

About Joakim Wijkstrom

The proxy statement of Vanda Pharmaceuticals Inc. reports total compensation of $1,457,528 for Joakim Wijkstrom in fiscal 2025, including a base salary of $579,600. Disclosed compensation is on record for 6 fiscal years. Vanda Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vanda Pharmaceuticals Inc. includes Mihael Polymeropoulos (CEO and Board Member), Kevin Moran (CFO), Anne Sempowski Ward (Board Member) and 6 others.

Affiliation history

Company network

Leadership on record at Vanda Pharmaceuticals Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Vanda Pharmaceuticals Inc. (VNDA) $579,600 $1,457,528
2024 Vanda Pharmaceuticals Inc. (VNDA) $560,000 $1,061,306
2023 Vanda Pharmaceuticals Inc. (VNDA) $560,000 $1,355,478
2022 Vanda Pharmaceuticals Inc. (VNDA) $553,320 $1,616,850
2021 Vanda Pharmaceuticals Inc. (VNDA) $522,000 $1,850,376
2020 Vanda Pharmaceuticals Inc. (VNDA) $506,422 $1,523,885

Recent activity

No call appearances or filed executive changes recorded yet.